Corporate'China Plus 1' Drives Early Wins for India’s Pharma Sector, Full Gains Expected in 3–5 YearsBY Outlook Business Desk
Economy & PolicyHigh tariffs on China create opportunities for India's manufacturing growth: CEABY Press Trust of India
Economy & PolicyIndia Emerges as Second-Highest Gainer from US Tariffs on China, Says Arvind VirmaniBY Parth Singh
